Pfizer
Pfizer sets out on $17 billion acquisition trail
July 21, 2006Sales and Marketing Pfizer
Pfizer, the world's biggest pharmaceutical company, has earmarked $17 billion to spend on new products and technologies over the next …
Biotech buy helps Pfizer expand neuroscience research
April 26, 2006Research and Development, Sales and Marketing Pfizer
Pfizer is to buy Californian Rinat Neuroscience, a biotech company which specialises in developing therapeutic proteins to treat central nervous …
Pfizer to go it alone with Exubera
January 16, 2006Sales and Marketing Exubera, Pfizer, diabetes, inhaled insulin
Pfizer has paid $1.3 billion to buy out its marketing partner’s stake in new inhaled diabetes drug Exubera.The US company …
R&D Scoreboard poor gauge of pharma investment in the UK
November 8, 2005Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard
The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
Pharma continues to invest in UK research and development
October 24, 2005Sales and Marketing Pfizer, R&D
UK pharma and biotech companies increased R&D investment by 4% in the last year, according to the latest government figures.The …
Industry braced for new upheaval in primary care
September 8, 2005Sales and Marketing NHS, PCTs, Pfizer
Likely reductions in the number of PCTs could prove disruptive to pharmaceutical companies – but the development of another NHS …
Pfizer pulls out of Daxas collaboration
July 7, 2005Sales and Marketing Daxas, Nycomed, Pfizer
Pfizer has pulled out of an agreement with Altana Pharma to develop and market a new treatment for asthma and …
Pfizer UK recruiting for new customer-focused salesforce
July 8, 2004NHS, Pfizer, salesforce
Pfizer has unveiled a new, restructured UK sales team designed to meet the needs of the NHS by aligning its …
A tale of two pills for Pfizer in Q1
April 26, 2004Pfizer, torceptrapib
The first quarter of 2004 saw Pfizer’s biggest seller Lipitor extend its domination of the statin market but Viagra, another …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
